Exact Mass: 357.1688

Exact Mass Matches: 357.1688

Found 120 metabolites which its exact mass value is equals to given mass value 357.1688, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Uplandicine

Uplandicine; 7-Acetyl-9-echimidinylretronecine

C17H27NO7 (357.1787)


   

5-Chloro-2-(3,5-di-tert-butyl-2-hydroxyphenyl)-2H-benzotriazole

2-(5-chloro-2H-Benzotriazol-2-yl)-4,6-bis(1,1-dimethylethyl)phenol, 9ci

C20H24ClN3O (357.1608)


5-Chloro-2-(3,5-di-tert-butyl-2-hydroxyphenyl)-2H-benzotriazole is a fda approved for use in food-contact polymers. FDA approved for use in food-contact polymers

   

Cinacalcet

alpha-Methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphar)-hydrochloride

C22H22F3N (357.1704)


Cinacalcet (INN) is a drug that acts as a calcimimetic (i.e. it mimics the action of calcium on tissues) by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. It is sold by Amgen under the trade name Sensipar in North America and Australia and as Mimpara in Europe. Cinacalcet is used to treat hyperparathyroidism (elevated parathyroid hormone levels), a consequence of parathyroid tumors and chronic renal failure. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D057966 - Calcimimetic Agents H - Systemic hormonal preparations, excl. sex hormones and insulins > H05 - Calcium homeostasis > H05B - Anti-parathyroid agents C78275 - Agent Affecting Blood or Body Fluid > C2136 - Malignancy-Associated Hypercalcemia Inhibitor D000077264 - Calcium-Regulating Hormones and Agents

   

(3R,5R)-3-Butyl-3-ethyl-5-phenyl-4,5-dihydro-2H-1$l^{6},4-benzothiazepine 1,1-dioxide

(3R,5R)-3-Butyl-3-ethyl-5-phenyl-4,5-dihydro-2H-1$l^{6},4-benzothiazepine 1,1-dioxide

C21H27NO2S (357.1762)


   

Quinocarmycin analog

12-cyano-10-(hydroxymethyl)-8-methoxy-16-methyl-11,16-diazatetracyclo[11.2.1.0^{2,11}.0^{4,9}]hexadeca-4(9),5,7-triene-15-carboxylic acid

C19H23N3O4 (357.1688)


D000970 - Antineoplastic Agents

   

Trelagliptin

2-{[6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl]methyl}-4-fluorobenzonitrile

C18H20FN5O2 (357.1601)


   
   

Porothramycin B

Porothramycin B

C19H23N3O4 (357.1688)


   

JWH 018 4-hydroxyindole metabolite

(4-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C24H23NO2 (357.1729)


   

DTXSID301017815

DTXSID301017815

C24H23NO2 (357.1729)


   

JWH 018 5-hydroxyindole metabolite

(5-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C24H23NO2 (357.1729)


   

(6-hydroxy-1-pentylindol-3-yl)-naphthalen-1-ylmethanone

(6-hydroxy-1-pentylindol-3-yl)-naphthalen-1-ylmethanone

C24H23NO2 (357.1729)


   

JWH 018 7-hydroxyindole metabolite

(7-hydroxy-1-pentyl-1H-indol-3-yl)naphthalen-1-yl)-methanone

C24H23NO2 (357.1729)


   
   

UNII-B3EM4XQ2QX

UNII-B3EM4XQ2QX

C24H23NO2 (357.1729)


   

(1-butylindol-3-yl)-(4-methoxynaphthalen-1-yl)methanone

(1-butylindol-3-yl)-(4-methoxynaphthalen-1-yl)methanone

C24H23NO2 (357.1729)


   
   

CHEMBL3526291

CHEMBL3526291

C24H23NO2 (357.1729)


   
   

Mazethramycin C

Mazethramycin C

C19H23N3O4 (357.1688)


   
   

MCULE-2632208911

MCULE-2632208911

C19H23N3O4 (357.1688)


   

DTXSID601018131

DTXSID601018131

C24H23NO2 (357.1729)


   
   
   
   
   

DTXSID301017865

DTXSID301017865

C24H23NO2 (357.1729)


   
   

3-Acetylindicine N-oxide

3-Acetylindicine N-oxide

C17H27NO7 (357.1787)


   

C19H23N3O4_2H-Pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione, 6-acetyl-6,10b,11,11a-tetrahydro-10b-hydroxy-3-(2-methylpropyl)

NCGC00380403-01_C19H23N3O4_2H-Pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione, 6-acetyl-6,10b,11,11a-tetrahydro-10b-hydroxy-3-(2-methylpropyl)-

C19H23N3O4 (357.1688)


   

Ala Gly Asn Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O6 (357.1648)


   

Ala Gly Pro Asn

(2S)-2-{[(2S)-1-{2-[(2S)-2-aminopropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C14H23N5O6 (357.1648)


   

Ala Asn Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

C14H23N5O6 (357.1648)


   

Ala Asn Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetic acid

C14H23N5O6 (357.1648)


   

Ala Pro Gly Asn

(2S)-2-(2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-carbamoylpropanoic acid

C14H23N5O6 (357.1648)


   

Ala Pro Asn Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]acetic acid

C14H23N5O6 (357.1648)


   

Gly Ala Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O6 (357.1648)


   

Gly Ala Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)propanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C14H23N5O6 (357.1648)


   

Gly Gly Pro Gln

(2S)-2-{[(2S)-1-[2-(2-aminoacetamido)acetyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C14H23N5O6 (357.1648)


   

Gly Gly Gln Pro

(2S)-1-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O6 (357.1648)


   

Gly Asn Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O6 (357.1648)


   

Gly Asn Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C14H23N5O6 (357.1648)


   

Gly Pro Ala Asn

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}propanamido]-3-carbamoylpropanoic acid

C14H23N5O6 (357.1648)


   

Gly Pro Gly Gln

(2S)-2-(2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}acetamido)-4-carbamoylbutanoic acid

C14H23N5O6 (357.1648)


   

Gly Pro Asn Ala

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]propanoic acid

C14H23N5O6 (357.1648)


   

Gly Pro Gln Gly

2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]acetic acid

C14H23N5O6 (357.1648)


   

Gly Gln Gly Pro

(2S)-1-{2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C14H23N5O6 (357.1648)


   

Gly Gln Pro Gly

2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C14H23N5O6 (357.1648)


   
   
   

Asn Ala Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]acetyl}pyrrolidine-2-carboxylic acid

C14H23N5O6 (357.1648)


   

Asn Ala Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanoyl]pyrrolidin-2-yl]formamido}acetic acid

C14H23N5O6 (357.1648)


   

Asn Gly Ala Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}propanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O6 (357.1648)


   

Asn Gly Pro Ala

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetyl}pyrrolidin-2-yl]formamido}propanoic acid

C14H23N5O6 (357.1648)


   

Asn Pro Ala Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]acetic acid

C14H23N5O6 (357.1648)


   

Asn Pro Gly Ala

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)propanoic acid

C14H23N5O6 (357.1648)


   

Pro Ala Gly Asn

(2S)-3-carbamoyl-2-{2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}propanoic acid

C14H23N5O6 (357.1648)


   

Pro Ala Asn Gly

2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]acetic acid

C14H23N5O6 (357.1648)


   
   

Pro Gly Ala Asn

(2S)-3-carbamoyl-2-[(2S)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]propanoic acid

C14H23N5O6 (357.1648)


   

Pro Gly Gly Gln

(2S)-4-carbamoyl-2-(2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}acetamido)butanoic acid

C14H23N5O6 (357.1648)


   

Pro Gly Asn Ala

(2S)-2-[(2S)-3-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]propanoic acid

C14H23N5O6 (357.1648)


   

Pro Gly Gln Gly

2-[(2S)-4-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]acetic acid

C14H23N5O6 (357.1648)


   

Pro Asn Ala Gly

2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]acetic acid

C14H23N5O6 (357.1648)


   

Pro Asn Gly Ala

(2S)-2-{2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}propanoic acid

C14H23N5O6 (357.1648)


   

Pro Gln Gly Gly

2-{2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}acetic acid

C14H23N5O6 (357.1648)


   

Gln Gly Gly Pro

(2S)-1-(2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}acetyl)pyrrolidine-2-carboxylic acid

C14H23N5O6 (357.1648)


   

Gln Gly Pro Gly

2-{[(2S)-1-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetyl}pyrrolidin-2-yl]formamido}acetic acid

C14H23N5O6 (357.1648)


   

Gln Pro Gly Gly

2-(2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)acetic acid

C14H23N5O6 (357.1648)


   
   

JWH 018 2-hydroxyindole metabolite

(2-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C24H23NO2 (357.1729)


   

JWH 018 6-hydroxyindole metabolite

(6-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C24H23NO2 (357.1729)


   

JWH 018 N-(5-hydroxypentyl) metabolite

(1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C24H23NO2 (357.1729)


   

Cinacalcet

[(1R)-1-(naphthalen-1-yl)ethyl]({3-[3-(trifluoromethyl)phenyl]propyl})amine

C22H22F3N (357.1704)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D057966 - Calcimimetic Agents H - Systemic hormonal preparations, excl. sex hormones and insulins > H05 - Calcium homeostasis > H05B - Anti-parathyroid agents C78275 - Agent Affecting Blood or Body Fluid > C2136 - Malignancy-Associated Hypercalcemia Inhibitor D000077264 - Calcium-Regulating Hormones and Agents

   

2,4-Di-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phenol

2-(5-chloro-2H-Benzotriazol-2-yl)-4,6-bis(1,1-dimethylethyl)phenol, 9ci

C20H24ClN3O (357.1608)


   

(S)-(+)-JWH 018 N-(4-hydroxypentyl) metabolite

(S)-(+)-JWH 018 N-(4-hydroxypentyl) metabolite

C24H23NO2 (357.1729)


   

(±)-JWH 018 N-(3-hydroxypentyl) metabolite

(±)-JWH 018 N-(3-hydroxypentyl) metabolite

C24H23NO2 (357.1729)


   

(±)-JWH 018 N-(2-hydroxypentyl) metabolite

(±)-JWH 018 N-(2-hydroxypentyl) metabolite

C24H23NO2 (357.1729)


   

6-Acetyl-10b-hydroxy-3-isobutyl-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

6-Acetyl-10b-hydroxy-3-isobutyl-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

C19H23N3O4 (357.1688)


   

4-ISOTHIOCYANATOPHENYL 4-PENTYLBICYCLO

4-ISOTHIOCYANATOPHENYL 4-PENTYLBICYCLO

C21H27NO2S (357.1762)


   

(S)-(+)-3-METHYL-2-BUTYLAMINE

(S)-(+)-3-METHYL-2-BUTYLAMINE

C24H23NO2 (357.1729)


   

5-[[p-(benzylmethylamino)phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium chloride

5-[[p-(benzylmethylamino)phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium chloride

C18H22ClN6 (357.1594)


   

2-((tert-butyldiphenylsilyl)oxy)-N-methoxy-N-methylacetamide

2-((tert-butyldiphenylsilyl)oxy)-N-methoxy-N-methylacetamide

C20H27NO3Si (357.176)


   

TERT-BUTYL N-[5-(TOSYLOXY)PENTYL]CARBAMATE

TERT-BUTYL N-[5-(TOSYLOXY)PENTYL]CARBAMATE

C17H27NO5S (357.161)


   

4,7-dimethyl-5,6-bis(phenylmethoxy)-1H-indole

4,7-dimethyl-5,6-bis(phenylmethoxy)-1H-indole

C24H23NO2 (357.1729)


   

(R)-(-)-5-(TRITYLOXYMETHYL)-2-PYRROLIDONE

(R)-(-)-5-(TRITYLOXYMETHYL)-2-PYRROLIDONE

C24H23NO2 (357.1729)


   

4-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)phenyl]morpholine

4-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)phenyl]morpholine

C17H23BF3NO3 (357.1723)


   

Trelagliptin

Trelagliptin

C18H20FN5O2 (357.1601)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(4-(trifluoroMethyl)phenyl)propan-1-aMine

(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(4-(trifluoroMethyl)phenyl)propan-1-aMine

C22H22F3N (357.1704)


   

Cinacalcet Impurity 13

Cinacalcet Impurity 13

C22H22F3N (357.1704)


   

N-Biotinyl-6-aminohexanoic acid

6-[5-(2-Oxo-hexahydro-thieno[3,4-D]imidazol-4-YL)-pentanoylamino]-hexanoic acid

C16H27N3O4S (357.1722)


   

(2S,3R)-N-(2-(3-Pyridinylmethyl)-1-azabicyclo(2.2.2)oct-3-yl)-3,5-difluorobenzamide

(2S,3R)-N-(2-(3-Pyridinylmethyl)-1-azabicyclo(2.2.2)oct-3-yl)-3,5-difluorobenzamide

C20H21F2N3O (357.1653)


   

4-(2-Pyridyl)piperazinyl 3,4,5-trimethoxyphenyl ketone

4-(2-Pyridyl)piperazinyl 3,4,5-trimethoxyphenyl ketone

C19H23N3O4 (357.1688)


   

3-[[2-(3,5-Dimethylpyrazol-1-yl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl]amino]propan-1-ol

3-[[2-(3,5-Dimethylpyrazol-1-yl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl]amino]propan-1-ol

C18H23N5OS (357.1623)


   

Butachlor sulfonic acid

Butachlor sulfonic acid

C17H27NO5S (357.161)


   

5-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-3-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-1,2-oxazole

5-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-3-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-1,2-oxazole

C21H19N5O (357.159)


   

Protubonine A

Protubonine A

C19H23N3O4 (357.1688)


An organic heterotetracyclic compound that is 6,10b,11,11a-tetrahydro-H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-,4(3H,5aH)-dione substituted by an acetyl group at position 6, a hydroxy group at position 10b and a 2-methylpropyl group at position 3. It has been isolated from in Aspergillus species. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D054659 - Diketopiperazines

   

Pipemidic acid trihydrate

Pipemidic acid trihydrate

C14H23N5O6 (357.1648)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

   

1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-o-tolylurea

1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-o-tolylurea

C21H19N5O (357.159)


   

N-[[3-(4-fluorophenyl)-1-phenyl-4-pyrazolyl]methyl]-1-phenylmethanamine

N-[[3-(4-fluorophenyl)-1-phenyl-4-pyrazolyl]methyl]-1-phenylmethanamine

C23H20FN3 (357.1641)


   

N-[2-(3-methylphenoxy)ethyl]-5-(4-morpholinyl)-2-nitroaniline

N-[2-(3-methylphenoxy)ethyl]-5-(4-morpholinyl)-2-nitroaniline

C19H23N3O4 (357.1688)


   
   
   
   
   
   
   
   
   
   
   

2-(2-Hydroxy-3,5-di-tert-butylphenyl)-5-chlorobenzotriazole

2-(2-Hydroxy-3,5-di-tert-butylphenyl)-5-chlorobenzotriazole

C20H24ClN3O (357.1608)


   

NEO 376

NEO 376

C20H24ClN3O (357.1608)


NEO 376 is a selective modulator of 5-HT1 receptor, GABA receptor and dopamine receptor, with anti-psychotic actively.

   

16-acetyl-6,9-dihydroxy-4-(2-methylpropyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

16-acetyl-6,9-dihydroxy-4-(2-methylpropyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C19H23N3O4 (357.1688)


   

(1r,4s,7r,9r)-16-acetyl-6,9-dihydroxy-4-(2-methylpropyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1r,4s,7r,9r)-16-acetyl-6,9-dihydroxy-4-(2-methylpropyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C19H23N3O4 (357.1688)


   

(2e)-3-[(8r)-8,11-dimethoxy-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl]-n,n-dimethylprop-2-enamide

(2e)-3-[(8r)-8,11-dimethoxy-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl]-n,n-dimethylprop-2-enamide

C19H23N3O4 (357.1688)


   

3-{8,11-dimethoxy-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl}-n,n-dimethylprop-2-enamide

3-{8,11-dimethoxy-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl}-n,n-dimethylprop-2-enamide

C19H23N3O4 (357.1688)


   

(1r,3r,5s,6r)-8-methyl-6-(1h-pyrrole-2-carbonyloxy)-8-azabicyclo[3.2.1]octan-3-yl 1-methylpyrrole-2-carboxylate

(1r,3r,5s,6r)-8-methyl-6-(1h-pyrrole-2-carbonyloxy)-8-azabicyclo[3.2.1]octan-3-yl 1-methylpyrrole-2-carboxylate

C19H23N3O4 (357.1688)